Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

研究方向

Apoptosis 相关产品(2721)

  • GC11003 structure
    GC11003PP121
    CAS: 1092788-83-4
    纯度: >99.00%

    A potent dual inhibitor of tyrosine and phosphoinositide kinases

  • GC11015 structure
    GC11015PD168393
    CAS: 194423-15-9
    纯度: >98.50%

    An irreversible EGFR kinase inhibitor

  • GC11018 structure
    GC11018GSK1059615
    CAS: 958852-01-2
    纯度: >98.00%

    A potent PI3K inhibitor

  • GC11040 structure
    GC11040Borrelidin
    CAS: 7184-60-3
    纯度: >98.00%

    An antiangiogenic antibiotic

  • GC11068 structure
    GC11068GSK2656157
    CAS: 1337532-29-2
    纯度: >99.50% / >98.00%

    GSK2656157是一种具有高效选择性的可渗透细胞的ATP竞争性PERK(PKR样内质网激酶)抑制剂,IC₅₀值为0.9nM。

  • GC11078 structure
    GC11078MRS 2578
    CAS: 711019-86-2
    纯度: >98.00%

    MRS 2578是一种有效的、选择性的P2Y6受体拮抗剂(IC 50 =37nM)。

  • GC11087 structure
    GC11087Myristoleic Acid
    CAS: 544-64-9
    纯度: >99.00% / >98.00% / >97.00%

    Myristoleic Acid一种生物活性不饱和脂肪酸,能够从肉豆蔻科植物种子中提取,或由肉豆蔻酸通过生物体内的去饱和酶生物合成。

  • GC11089 structure
    GC11089SU11274
    CAS: 658084-23-2
    纯度: >98.00%

    A potent, selective inhibitor of c-Met

  • GC11097 structure
    GC11097MPTP hydrochloride
    CAS: 23007-85-4
    纯度: >98.00%

    MPTP(1-甲基-4-苯基-1,2,3,6-四氢吡啶)是一种神经毒性物质,它是MPP+的前体,对多巴胺能神经元有毒,并导致帕金森病。

  • GC11107 structure
    GC11107PF-573228
    CAS: 869288-64-2
    纯度: >99.50%

    A selective focal adhesion kinase inhibitor

  • GC11140 structure
    GC11140Radotinib(IY-5511)
    CAS: 926037-48-1

    A selective Bcr-Abl tyrosine kinase inhibitor

  • GC11141 structure
    GC11141BTZO 1
    CAS: 99420-15-2
    纯度: >99.50%

    An antioxidant response element activator with cardioprotective activity

  • GC11165 structure
    GC11165PI-103
    CAS: 371935-74-9
    纯度: >98.00%

    PI-103是一种有效的细胞渗透性多靶点抑制剂,主要作用于PI3K和mTOR信号通路。

  • GC11167 structure
    GC11167Necrostatin 2
    CAS: 852391-19-6
    纯度: >99.50%

    A potent inhibitor of necroptosis

  • GC11177 structure
    GC11177GDC-0980 (RG7422)
    CAS: 1032754-93-0
    纯度: >98.00%

    A dual inhibitor of PI3K and mTOR

  • GC11200 structure
    GC11200A23187
    CAS: 52665-69-7
    纯度: >98.00% / >98.50%

    A23187自由酸是一种Ca2+离子载体。

  • GC11202 structure
    GC11202Epothilone A
    CAS: 152044-53-6
    纯度: >98.50%

    An antimicrotubule agent

  • GC11217 structure
    GC11217CUR 61414
    CAS: 334998-36-6
    纯度: >99.00%

    A potent inhibitor of hedgehog-induced activity

  • GC11224 structure
    GC11224BI6727(Volasertib)
    CAS: 755038-65-4
    纯度: >99.00%

    BI6727(Volasertib)是一种口服ATP竞争性Polo样激酶(PLK)抑制剂,可强效抑制PLK1、PLK2和PLK3活性,IC 50 值分别为0.87nM、5nM和56nM。

  • GC11298 structure
    GC11298TH-302
    CAS: 918633-87-1
    纯度: >98.50%

    A hypoxia-activated anticancer agent

  • GC11302 structure
    GC11302Hinokitiol
    CAS: 499-44-5
    纯度: >99.50% / >98.00%

    Hinokitiol是一种在 Formosan cypress 中天然存在的tropolone类化合物,具有抗菌和抗癌特性。

  • GC11332 structure
    GC11332Pitavastatin
    CAS: 147511-69-1

    Pitavastatin是一种3-羟基-3-甲基戊二酰辅酶A(HMG-CoA)还原酶抑制剂,在Hep G2细胞中对HMG-CoA还原酶活性的IC 50 值为5.8nM。

  • GC11334 structure
    GC11334Romidepsin (FK228, depsipeptide)
    CAS: 128517-07-7
    纯度: >99.50%

    Romidepsin (FK228, depsipeptide)是一种有效且选择性的组蛋白去乙酰化酶(HDAC)抑制剂,抑制HDAC1,HDAC2,HDAC4和HDAC6的IC 50 值分别为36nM,47nM,510nM和1.4μM。

  • GC11383 structure
    GC11383CYT997 (Lexibulin)
    CAS: 917111-44-5
    纯度: >98.00%

    An inhibitor of microtubule polymerization